Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Peter Gale

Showing results (151-160 of 557) with videos related to

Pageof 56
Sort By:
Haematologica|May 21, 2026
Response to Comment on: "Clonal megakaryocyte dysplasia with normal blood values: a covert, thrombosis-prone, early myeloproliferative neoplasm."Giovanni Barosi, Vittorio Rosti, Luca Malcovati, et al.
Leukemia|May 13, 2020
Chronic lymphocytic leukemia in 2020: a surfeit of riches?Sameer A Parikh, Robert Peter Gale, Neil E Kay
Clinical Lymphoma, Myeloma & Leukemia|January 1, 2025
A Review of Clonal Relationships in Myeloproliferative Neoplasms With Co-Mutations of JAK2, CALR or MPL and BCR::ABL1Mohammadamin Noorafrooz, Sanaz Ghods, Robert Peter Gale, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 25, 2013
Improving survival in acute myeloid leukemia: pick the best subjects?Hillard M Lazarus, Mark R Litzow, Robert Peter Gale
Leukemia|March 6, 2020
Should persons with acute myeloid leukemia (AML) in 1st histological complete remission who are measurable residual disease (MRD) test positive receive an allotransplant?Adriano Venditti, Robert Peter Gale, Francesco Buccisano, et al.
Journal of Radiological Protection : Official Journal of the Society for Radiological Protection|June 16, 2021
Role of molecularly-cloned hematopoietic growth factors after acute high-dose radiation exposuresHillard M Lazarus, James O Armitage, Robert Peter Gale
Leukemia Research|January 21, 2014
Therapy-related AML: a slip of the lip can sink a shipRobert Peter Gale, John M Bennett, F Owen Hoffman
Leukemia|September 9, 2020
Roger Herschel Herzig: younger half of the dynamic duo which advanced leukaemia therapy and transplants: January 4, 1946 to July 18, 2020Robert Peter Gale, Hillard M Lazarus, Gordon L Phillips
Blood Reviews|September 30, 2017
Immunoglobulin therapy in hematologic neoplasms and after hematopoietic cell transplantationMasumi Ueda, Melvin Berger, Robert Peter Gale, et al.
Clinical Transplants|August 7, 2014
2013 report from the Center for International Blood and Marrow Transplant Research (CIBMTR): current uses and outcomes of hematopoietic cell transplants for blood and bone marrow disordersMarcelo Pasquini, Zhiwei Wang, Mary M Horowitz, et al.
Pageof 56

Showing results (151-160 of 557) with videos related to

Sort By:
Pageof 56
Haematologica|May 21, 2026
Response to Comment on: "Clonal megakaryocyte dysplasia with normal blood values: a covert, thrombosis-prone, early myeloproliferative neoplasm."Giovanni Barosi, Vittorio Rosti, Luca Malcovati, et al.
Leukemia|May 13, 2020
Chronic lymphocytic leukemia in 2020: a surfeit of riches?Sameer A Parikh, Robert Peter Gale, Neil E Kay
Clinical Lymphoma, Myeloma & Leukemia|January 1, 2025
A Review of Clonal Relationships in Myeloproliferative Neoplasms With Co-Mutations of JAK2, CALR or MPL and BCR::ABL1Mohammadamin Noorafrooz, Sanaz Ghods, Robert Peter Gale, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 25, 2013
Improving survival in acute myeloid leukemia: pick the best subjects?Hillard M Lazarus, Mark R Litzow, Robert Peter Gale
Leukemia|March 6, 2020
Should persons with acute myeloid leukemia (AML) in 1st histological complete remission who are measurable residual disease (MRD) test positive receive an allotransplant?Adriano Venditti, Robert Peter Gale, Francesco Buccisano, et al.
Journal of Radiological Protection : Official Journal of the Society for Radiological Protection|June 16, 2021
Role of molecularly-cloned hematopoietic growth factors after acute high-dose radiation exposuresHillard M Lazarus, James O Armitage, Robert Peter Gale
Leukemia Research|January 21, 2014
Therapy-related AML: a slip of the lip can sink a shipRobert Peter Gale, John M Bennett, F Owen Hoffman
Leukemia|September 9, 2020
Roger Herschel Herzig: younger half of the dynamic duo which advanced leukaemia therapy and transplants: January 4, 1946 to July 18, 2020Robert Peter Gale, Hillard M Lazarus, Gordon L Phillips
Blood Reviews|September 30, 2017
Immunoglobulin therapy in hematologic neoplasms and after hematopoietic cell transplantationMasumi Ueda, Melvin Berger, Robert Peter Gale, et al.
Clinical Transplants|August 7, 2014
2013 report from the Center for International Blood and Marrow Transplant Research (CIBMTR): current uses and outcomes of hematopoietic cell transplants for blood and bone marrow disordersMarcelo Pasquini, Zhiwei Wang, Mary M Horowitz, et al.
Pageof 56